Abeona Therapeutics annual revenue
2010
2011
2012
2013
2014
2015
2016
2017
2018
2020
2021
2022
2023
2024
2025
Abeona Therapeutics Revenue Growth & History (ABEO)
Abeona Therapeutics reported $5.8M in revenue for fiscal 2025.
View full Abeona Therapeutics company overviewAbeona Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.8M | $5.8M | — |
| 2024 | 2024-12-31 | $0 | −$3.5M | −100.00% |
| 2023 | 2023-12-31 | $3.5M | $2.1M | +147.52% |
| 2022 | 2022-12-31 | $1.4M | −$1.6M | −52.87% |
| 2021 | 2021-12-31 | $3.0M | −$7.0M | −70.00% |
| 2020 | 2020-12-31 | $10.0M | — | — |
| 2018 | 2018-12-31 | $3.0M | $2.2M | +258.18% |
| 2017 | 2017-12-31 | $837,000 | −$52,000 | −5.85% |
| 2016 | 2016-12-31 | $889,000 | −$151,000 | −14.52% |
| 2015 | 2015-12-31 | $1.0M | $115,000 | +12.43% |
| 2014 | 2014-12-31 | $925,000 | −$1.1M | −54.70% |
| 2013 | 2013-12-31 | $2.0M | −$2.4M | −53.63% |
| 2012 | 2012-12-31 | $4.4M | $2.6M | +139.48% |
| 2011 | 2011-12-31 | $1.8M | $1.4M | +282.33% |
| 2010 | 2010-12-31 | $481,000 | — | — |
Abeona Therapeutics quarterly revenue
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.20
Q1.22
Q2.22
Q3.22
Q4.22
Q2.23
Q3.23
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $11.4M | $11.0M | +2745.00% |
| Q1 2026 | 2026-03-31 | $8.7M | $8.7M | — |
| Q4 2025 | 2025-12-31 | $5.4M | — | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $400,000 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q3 2023 | 2023-09-30 | $0 | $0 | — |
| Q2 2023 | 2023-06-30 | $3.5M | $2.5M | +250.00% |
| Q4 2022 | 2022-12-31 | $68,000 | — | — |
| Q3 2022 | 2022-09-30 | $0 | — | — |
| Q2 2022 | 2022-06-30 | $1.0M | — | — |
| Q1 2022 | 2022-03-31 | $346,000 | — | — |
| Q3 2020 | 2020-09-30 | $7.0M | — | — |
| Q2 2019 | 2019-06-30 | $0 | −$819,000 | −100.00% |
| Q1 2019 | 2019-03-31 | $0 | −$531,000 | −100.00% |
| Q4 2018 | 2018-12-31 | −$61,000 | −$276,000 | −128.37% |
| Q3 2018 | 2018-09-30 | $1.7M | $1.5M | +680.37% |
| Q2 2018 | 2018-06-30 | $819,000 | $602,000 | +277.42% |
| Q1 2018 | 2018-03-31 | $531,000 | $345,000 | +185.48% |
| Q4 2017 | 2017-12-31 | $215,000 | −$41,000 | −16.02% |
| Q3 2017 | 2017-09-30 | $219,000 | $35,000 | +19.02% |
| Q2 2017 | 2017-06-30 | $217,000 | $3,000 | +1.40% |
| Q1 2017 | 2017-03-31 | $186,000 | −$49,000 | −20.85% |
| Q4 2016 | 2016-12-31 | $256,000 | $41,000 | +19.07% |
| Q3 2016 | 2016-09-30 | $184,000 | −$101,000 | −35.44% |
| Q2 2016 | 2016-06-30 | $214,000 | −$68,000 | −24.11% |
| Q1 2016 | 2016-03-31 | $235,000 | −$23,000 | −8.91% |
| Q4 2015 | 2015-12-31 | $215,000 | −$19,000 | −8.12% |
| Q3 2015 | 2015-09-30 | $285,000 | $49,000 | +20.76% |
| Q2 2015 | 2015-06-30 | $282,000 | $35,000 | +14.17% |
| Q1 2015 | 2015-03-31 | $258,000 | $50,000 | +24.04% |
| Q4 2014 | 2014-12-31 | $234,000 | $72,000 | +44.44% |
| Q3 2014 | 2014-09-30 | $236,000 | $47,000 | +24.87% |
| Q2 2014 | 2014-06-30 | $247,000 | −$220,000 | −47.11% |
| Q1 2014 | 2014-03-31 | $208,000 | −$1.0M | −83.01% |
| Q4 2013 | 2013-12-31 | $162,000 | −$844,000 | −83.90% |
| Q3 2013 | 2013-09-30 | $189,000 | −$682,000 | −78.30% |
| Q2 2013 | 2013-06-30 | $467,000 | −$223,000 | −32.32% |
| Q1 2013 | 2013-03-31 | $1.2M | −$613,000 | −33.37% |
| Q4 2012 | 2012-12-31 | $1.0M | $509,000 | +102.41% |
| Q3 2012 | 2012-09-30 | $871,000 | −$170,000 | −16.33% |
| Q2 2012 | 2012-06-30 | $690,000 | $539,000 | +356.95% |
| Q1 2012 | 2012-03-31 | $1.8M | $1.7M | +1124.67% |
| Q4 2011 | 2011-12-31 | $497,000 | — | — |
| Q3 2011 | 2011-09-30 | $1.0M | $914,000 | +719.69% |
| Q2 2011 | 2011-06-30 | $151,000 | $46,000 | +43.81% |
| Q1 2011 | 2011-03-31 | $150,000 | — | — |
| Q3 2010 | 2010-09-30 | $127,000 | — | — |
| Q2 2010 | 2010-06-30 | $105,000 | — | — |
Abeona Therapeutics revenue growth trends
Over the last five reported fiscal years, revenue declined from $10.0M to $5.8M, a compound annual decline of 10.26%. Abeona Therapeutics's latest reported quarter, Q2 2026, generated $11.4M in revenue, an increase of 2745.00% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Abeona Therapeutics source filings ↗